Herbert Irving Comprehensive Cancer Center

Herbert Irving Comprehensive Cancer Center (HICCC) is a National Cancer Institute NCI-designated Cancer Center, founded in 1911 and located at NewYork-Presbyterian / Columbia University Irving Medical Center (NYP/CUIMC).

The HICCC has more than 250 faculty members, 12 core facilities, and eight research programs within three divisions.





== Research ==



There are eight research programs at HICCC divided into three divisions. The basic research division includes programs in cancer regulatory networks and cancer genetics and epigenetics. Programs in the disease-specific division focus on breast cancer, hematological cancer, prostate cancer, and neuro-oncology. The population science division includes cancer epidemiology and prevention, control, and disparities.

The center is currently receiving over $33 million in funding from the National Institutes of Health.





== Patient Care ==

Patients are treated at NewYork-Presbyterian Hospital/Columbia. HICCC physicians treat more than 3,500 patients annually. There are over 200 clinical trials available to patients.